Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition
Giulia Pinton,
Zhuo Wang,
Cecilia Balzano,
Sara Missaglia,
Daniela Tavian,
Renzo Boldorini,
Dean A. Fennell,
Martin Griffin,
Laura Moro
Affiliations
Giulia Pinton
Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), Novara, Italy
Zhuo Wang
School of Life and Health Sciences, Aston University, Birmingham, United Kingdom
Cecilia Balzano
Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), Novara, Italy
Sara Missaglia
Laboratory of Cellular Biochemistry and Molecular Biology, Centro di Ricerca in Biochimica E Nutrizione dello Sport (CRIBENS), Catholic University of the Sacred Heart, Milan, Italy
Daniela Tavian
Laboratory of Cellular Biochemistry and Molecular Biology, Centro di Ricerca in Biochimica E Nutrizione dello Sport (CRIBENS), Catholic University of the Sacred Heart, Milan, Italy
Renzo Boldorini
Department of Health Science, University of Piemonte Orientale (UPO), Novara, Italy
Dean A. Fennell
Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom
Martin Griffin
School of Life and Health Sciences, Aston University, Birmingham, United Kingdom
Laura Moro
Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), Novara, Italy
